The SARM1 TIR domain produces glycocyclic ADPR molecules as minor products

• Jeremy Garb ,

  Contributed equally to this work with: Jeremy Garb, Gil Amitai

  Roles Investigation, Writing – review & editing

  Affiliation Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel

  https://orcid.org/0009-0002-1010-8069

  ⨯
• Gil Amitai ,

  Contributed equally to this work with: Jeremy Garb, Gil Amitai

  Roles Investigation

  Affiliation Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel

  ⨯
• Allen Lu,

  Roles Investigation

  Affiliations Department of Microbiology, Harvard Medical School, Boston, MA, United States of America, Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, United States of America

  https://orcid.org/0000-0001-7353-4300

  ⨯
• Gal Ofir,

  Roles Writing – review & editing

  Current address: Department of Molecular Biology, Max Planck institute for Biology Tübingen, Tübingen, Germany

  Affiliation Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel

  ⨯
• Alexander Brandis,

  Roles Data curation

  Affiliation Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel

  ⨯
• Tevie Mehlman,

  Roles Data curation

  Affiliation Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel

  ⨯
• Philip J. Kranzusch,

  Roles Writing – review & editing

  Affiliations Department of Microbiology, Harvard Medical School, Boston, MA, United States of America, Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, United States of America, Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute, Boston, MA, United States of America

  ⨯
• Rotem Sorek

  Roles Conceptualization, Writing – original draft

  * E-mail: rotem.sorek@weizmann.ac.il

  Affiliation Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel

  ⨯